NCT06448403Recruiting
Multimodal Assesment of Alzheimer Patients
Multimodal Assessment of Cognitive Impairment in Alzheimer Patients
Source: ClinicalTrials.gov · Last updated 13 Aug 2026
Brief summary (registry, in English)
The goal of this study is to learn more about the changes in the brains of patients with cognitive impairment (MCI) and Alzheimer's Disease (AD). The main questions the study aims to answer are: 1. What findings can be used to earlier detect patients that will develop Alzheimers? 2. Which differences are seen between healthy and cognitively impaired patients? 3. Which differences are seen between patients with Alzheimers disease? Participants will undergo: * Cognitive tests * Magnetic resonance imaging (MRI) * Electroencephalography (EEG) * Blood sample collection * Fecal sample collection * A randomized group will undergo polysomnography analysis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 3 Jun 2024
- Start date
- 1 Jul 2024
- Primary completion date
- 29 Dec 2030
- Lead sponsor
- Norwegian University of Science and Technology
- Diseases
- Alzheimer disease
- NCT number
- NCT06448403
What you commit to
- Study type: Observational
- Planned participants: 60
- From 1 Jul 2024 to the primary completion date, 29 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other neyrodegenerative diseases (i.e Parkinson and ALS)
- Diseases related to inflammation and auto-immunity (i.e MS)
Age
- AD diagnosis before the age of 65 (Early-onset AD).
Other
- Uneligibility for any of the planned neuroimagery devices (MRI, EEG)
- Brain tumor
- Traumtic head injury
- Earlier neurosurgery
Who the study is looking for
- MCI and AD according to relevant ICD-criterias.
- Control cohort is age and gender matched with other cohorts.
Age in the registry: 65 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU) Coordinator of this site? Confirm its status | Trondheim | Norway | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.